Silicon Therapeutics, a privately-held, fully integrated drug design, discovery and development company focused on small molecule therapeutics, today introduced an updated corporate website, which reflects the company’s mission, research approach and core values.
The new Silicon Therapeutics site more accurately tells the company’s story and clearly highlights the company’s mission to improve the lives of patients by creating novel, disease-modifying medicines for challenging targets, using its proprietary, quantum physics-driven discovery engine.
“We worked to develop a meaningful brand architecture and visual identity that embodies the company’s strategic approach and core ethos,” said Lanny Sun, co-founder and chief executive officer. “This project has been part of our strategy to more fully engage with investors, potential partners, scientists and future employees while highlighting our differentiated approach and the opportunities that our platform presents for the company.”
The new site is expanded with deeper scientific content and the layout is structured for ease